Marked socioeconomic inequalities in hip fracture incidence rates during the Bone and Joint Decade (2000-2010) in Portugal: age and sex temporal trends in a population based study by Oliveira, Carla Maria et al.
Marked socioeconomic inequalities in hip fracture
incidence rates during the Bone and Joint Decade
(2000–2010) in Portugal: age and sex temporal
trends in a population based study
Carla Maria Oliveira,1,2,3,4,5 Sandra Maria Alves,1,2,3 Maria Fátima Pina1,2,4,6,7
ABSTRACT
Background Socioeconomic factors may inﬂuence
changes in hip fracture (HF) incidence over time. We
analysed HF temporal trends during the Bone and Joint
Decade in Portugal (BJD-Portugal), 2000–2010, by
regional socioeconomic status (SES), sex and age.
Methods We selected registers of patients aged 50+
years with HF (International Classiﬁcation of Diseases,
V.9—Clinical Modiﬁcation, ICD9-CM) caused by traumas
of low/moderate energy, from the National Hospital
Discharge Database. Annual time series of age-speciﬁc
incidence rates were calculated by sex and regional SES
(deprived, medium, afﬂuent). Generalised additive
models were ﬁtted to identify shape/turning points in
temporal trends.
Results We selected 96 905 HF (77.3% in women).
Women were older than men at admission (81.2±8.5 vs
78.2±10.1 years-old, p<0.001). For women 65–
79 years, a continuously decreasing trend (1.7%/year)
only in afﬂuent and increasing trends (3.3–3.4%/year)
after 2006/2007 in medium and deprived was observed.
For men, trends were stable or increased in almost all
age/SES groups (only two decreasing periods). For the
oldest women, all SES present similar trends: turning
points around 2003 (initiating decreasing periods:
1.8–2.9%/year) and around 2007 (initiating increasing
periods: 3.7–3.3%/year).
Conclusions There were SES-sex-age inequalities in
temporal trends during BJD-Portugal: marked SES
inequalities among women aged 65–79 years (a
persistent, decreasing trend only in the afﬂuent)
vanished among the oldest women; the same was not
observed in men, for them, there were almost no
declining periods; women aged ≥80 years, presented
increasing trends around 2007, as in most deprived/age/
sex groups. Despite some successful periods of
decreasing trends, incidence rates did not improve overall
in almost all age groups and both sexes.
INTRODUCTION
Hip fractures (HF), some of the most preventable
causes of disabilities in the elderly,1 are a major
public health problem because of their association
with high morbidity and mortality rates, and their
economic impact on individuals and societies.2
Therefore, HP were included among the disorders
prioritised by the Bone and Joint Decade (BJD) ini-
tiative. This initiative resulted from the concern of
healthcare professionals over the signiﬁcant impact
of these disorders on society, the healthcare system
and individuals. Launched in 2000 and running
until 2010, its primary aim was to promote
advances in the knowledge, diagnosis and treat-
ment of musculoskeletal disorders. The goal of the
BJD was: “to improve the health-related quality of
life for people with musculoskeletal disorders
throughout the world by raising awareness and pro-
moting positive actions to combat the suffering and
costs to society, associated with musculoskeletal dis-
orders”3 More than 60 countries, including
Portugal, signed this initiative4 and made commit-
ments to reduce HF incidence. The BJD was
renewed for the decade 2010–2020 as a global alli-
ance for musculoskeletal health.5 6
It is known that socioeconomic factors are deter-
minants for disparities in health behaviours, and inci-
dence of diseases and mortality;7 an inverse
association between several health outcomes and
socioeconomic status (SES) has been reported:
deprived SES individuals, or regions, present higher
morbidity and mortality rates in general.7 8 The
inverse association between SES and osteoporosis or
HF reported in the literature (not all of which is con-
sistent)9 10 might be partially explained by unhealthy
behaviours such as poor diet, inadequate exercise or
harmful occupational environments, which are more
frequent in deprived populations.7 11
Overall, strong inequalities in temporal trends of
HF incidence have been described between and
within countries.12 13 Several studies reported
increasing trends in HF incidence until the begin-
ning of the last decade (around 2000) and increas-
ing longevity—combined with socioeconomic,
demographic and environmental risk factors—have
been pointed out as a possible explanation.14 15
However, during the past decade (after 2000), sta-
bilisation or a decrease in HF incidence by sex and
age groups have also been described in most
Western countries and Oceania,16–20 and might be
the result of prevention strategies, either medical
(pharmaceutical treatment for osteoporosis) or
non-medical (fall prevention).21 22 Even though
temporal trends have been widely explored, studies
reporting differences in temporal trends by SES are
sparse and, to our knowledge, there are no studies
reporting how HF incidence rates have changed
over time in different regional SES per age group.
To overcome the gap in the literature, we con-
ducted a population-based study in Portugal with
the aim to analyse the temporal trends of HF inci-
dence rates during the BJD (2000–2010), by sex
and age group, according to municipality in SES
regions.
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MATERIAL AND METHODS
Study area
The study area is Continental Portugal—we excluded the two
autonomous regions, the archipelagos of Azores and Madeira (5%
of the Portuguese population), from the analysis because there
were no available data for these regions. In 2010, there were
1 005 799 inhabitants distributed heterogeneously throughout
278 municipalities, with a median of 15 741 (IQR 7371–39 356)
inhabitants per municipality. Portugal is one of the highest aged
countries in Europe-27: in 2010 it was the ﬁfth country in the
ranking of the highest percentage of persons aged 65 years and
over,23 with an ageing index of 120 elderly (≥65 years of age) per
100 youths (≤14 years of age) and 37.7% of the population over
50 years of age (INE—Statistics Portugal24).
Data
We used data from the National Hospital Discharge Register
(NHDR), mandatory for all Portuguese public hospitals since
1997. The quality of the NHDR is assessed regularly by internal
and external auditors. It is initially carried out in the hospital by
internal auditors and later by external auditors from the Central
Administration of the National System (ACSS). Internal and exter-
nal auditors are mandatory medical coders trained by the ACSS.
The evaluation of quality is performed systematically in order to
determine whether the encoding and resulting grouping Diagnosis
Related Groups (DRG) comply with the coding rules, and these
are effectively implemented in order to achieve the objectives of
the System Patient Classiﬁcation in DRG.25 More details about the
NHDR can be found elsewhere;25 brieﬂy, each register corre-
sponds to one episode of hospital admission and contains variables
such as sex, age, cause of admission (main and up to 19 secondary
causes) and diagnosis (main and up to 19 secondary diagnoses)
coded according to the International Classiﬁcation of Diseases, V.9
—Clinical Modiﬁcation (ICD9-CM), the municipality of patient’s
residence and the date of admission, among others. For reasons of
conﬁdentiality, data were available without information that would
allow identiﬁcation of the patient, such as name, code, address or
ID number. During the study period, access to the Portuguese
healthcare system (health centres, and hospital consultations and
internments) was based on principles of universality, integrality
and equity, and were mostly free-of-charge: contributions were
based on citizens’ socioeconomic conditions26 and almost all the
patients with HF were treated in public hospitals. Therefore, data
of HF hospital admissions from the NHDR can be seen as a proxy
of HF incidence in Portugal.
We selected all hospital discharge registers of patients hospita-
lised from 1 January 2000 to 31 December 2010, aged 50 years
and over, with a diagnosis of HF (main, second or third diagno-
sis) (ICD9-CM codes 820.x) with the main cause being trauma
of low/moderate energy (main cause of admission) (ICD9-CM
codes E849.0, E849.7 and E880-E888). We excluded readmis-
sions for aftercare (ICD9-CM codes 996.4 and V54.x) and
pathological fractures (ICD9-CM codes 170.x and 171.x) if
registered in 1 of the 20. Procedure codes were also taken into
consideration to detect and exclude cases with a misclassiﬁcation
readmission on the diagnosis ﬁeld. Cases with a length of stay
less than 5 days and transferred to another hospital without
surgery were also excluded (the ﬁrst hospitalisation could only
be for stabilisation of the patient). Counts of HF were stratiﬁed
by the municipality of patient’s residence, admission year, sex
and three age groups (50–64, 65–79, 80+ years).
For age-speciﬁc incidence rates, we used population counts
per municipality from the 2001 Census and from the ofﬁcial
estimates for all the other years,24 stratiﬁed in the same groups
of hospital admission data.
Each municipality was classiﬁed according to SES, as deprived,
medium or afﬂuent; analyses were conducted according to the
region’s SES. The methods for the classiﬁcation of municipalities
according to SES can be found in detail elsewhere.27 In brief, we
reduced a set of 30 socioeconomic and demographic variables
related to building, households, families and individuals from the
2001 census into four principal components (PCs), based on the
Kaiser Criterion (eigenvalues ≥1), which retained 75.8% of the
total variability. A varimax rotation was then applied to the four
PCs for interpretation and to reduce the dimensionality of the
data at a set of uncorrelated variables that account for much of
the original data. Later, we conducted a hierarchical cluster ana-
lysis based on Ward’s method to identify homogenous areas.
Municipalities were then aggregated in three clusters of SES that
were empirically interpreted as follows: the afﬂuent SES com-
prises municipalities with younger population, higher educa-
tional level, higher percentage of employed individuals, good
housing conditions (plumbing, heating, shower and bathroom
facilities); compared to the afﬂuent areas, the medium SES com-
prises municipalities with older populations, higher illiteracy
rates, a lower gross domestic product (GDP) per capita and a
higher percentage of individuals employed in agricultural, for-
estry and industry; compared to the afﬂuent and medium areas,
the deprived SES comprises municipalities with the highest per-
centage of elderly, the highest illiteracy rate, the highest rate of
people living alone, the lowest level of education, the lowest
GDP per capita, the highest percentage of individuals with rural
activities, the highest percentage of houses with no running
water, no shower and bathroom facilities, and the highest per-
centage of individuals receiving unemployment beneﬁts.28 The
population (≥50 years of age) signiﬁcantly differs by SES group
(p<0.001), with the median: 1607 (IQR 1207–2402) in the
deprived SES cluster; 3473 inhabitants (IQR 2386–6285) in the
medium SES cluster and 7426 inhabitants (IQR 3453–12 706) in
the afﬂuent SES cluster.
Statistical analysis
We computed annual time series of the age-speciﬁc incidence
rates, expressed as admissions per 100 000 persons-year (PY)
stratiﬁed by sex and regions’ SES. The age-speciﬁc incidence
rates were calculated dividing the total admissions by the total
population, per year, sex, SES and age groups 50–64, 65–79
and 80+ years (the total admissions and population for each
year, SES, sex and age group can be seen in online supplemen-
tary table S1).
Generalized additive models that incorporate a non-
parametric component, s(.), estimated using spline functions
(smoothers, useful in revealing possible non-linearities in the
effect of the predictors) were ﬁtted to identify shape and
turning points where the temporal trend changes signiﬁcantly in
magnitude and/or direction during the study period. Annual
(and period) absolute and relative changes over time were quan-
tiﬁed between turning points (or between turning points and
extremes, in the case of the ﬁrst and last period) of the time
series (more detail can be seen in online supplementary
methods 1).
We assumed that the number of HF (NFratt) in a speciﬁc year
t follows a Poisson distribution with mean lt ¼ NPopt@t, where
NPopt is the population in year t and @t is the incidence rate of
HF per unit of population in year t (or follows a negative bino-
mial distribution with the scale parameter u to account for
overdispersion).
For each sex, age group and regional SES, the parameters of
interest were estimated by the following model:
NFratt  Pois(lt) orNFratt  NegBin(lt; u)
log(lt)¼ log(NPopt)þ log(rt)¼ log (NPopt)þb0þb1s(YearðtÞ)
The statistical analysis was performed using the packages mgcv
and MASS of the statistical software R V.2.14.1 (Project for
Statistical Computing).
RESULTS
There were 98 186 admissions, of patients aged 50 years and
over, with a diagnosis of HF caused by traumas of low/moderate
energy in Continental Portugal between 2000 and 2010. From
those, we excluded 585 due to missing data in the municipality
of the patient’s residence and 696 due to readmissions for after
care; our ﬁnal sample includes 96 905 fractures (77.3% in
women). On average, women are older than men at admission,
with a mean age±SD of 81.2±8.5 vs 78.2±10.1 years of age,
p<0.001.
Figure 1 shows the temporal trends of age-speciﬁc incidence
rates (estimated rates for each year, SES, sex and age group are
presented in online supplementary table 2) and table 1 presents
the estimated absolute and relative changes in the trends of age-
speciﬁc incidence rates per 100 000 PY (95% CI), by regional
SES and age groups in women. Only among the group of oldest
women are there no differences in the trends of HF due to the
region’s SES—for this group, we observed a decreasing trend
from 2002/2004 to 2006/2007, followed by an increasing trend
until the end of the study period. In the other age groups, there
are marked SES differences in trends: for younger women (50–
64 years of age) there are no changes over time, except in the
afﬂuent regions, where there are slight decreasing trends (1.9%
HF per year) from 2000 to 2007. For women aged 65–
79 years: in the afﬂuent regions, there is a continuously decreas-
ing trend in the overall period (1.7% HF per year) while for the
medium regions, there is an abrupt decreasing trend (4.7% HF
per year) for a short period (2004–2007) followed by an
increasing trend (3.4% HF per year). On the other hand, in the
deprived regions, only an increasing trend was observed (2006–
2010), with an increment of 3.3% HF per year.
Similar analyses were conducted for men and the results are
presented in ﬁgure 2 and table 2. In general, men present fewer
differences in the trends compared to women. In younger men
(50–64 years of age), no signiﬁcant changes in the trends are
observed. In the 65–79-year age group, the afﬂuent regions
present a decrease of 1.8% HF per year between 2001 and
2007; on the contrary, the deprived regions have an annual
increase of 4.4% HF per year, from 2004 to 2010. For the
oldest men (≥80 years of age), a similar pattern was observed in
afﬂuent and deprived regions with a stable period followed by
an increasing tendency (2006–2010), signiﬁcant only in afﬂuent
regions (an increment of 1.6% HF per year). Contrary to the
other regional SES, the medium regions present a decreasing
trend from 2003 to 2007 (2.3% HF per year).
DISCUSSION
In this study, we aimed to analyse the temporal trends of age-
speciﬁc incidence rates of HP, by sex, age groups and regional
SES in Portugal, during the BJD (2000–2010). We found socio-
economic, age and sex inequalities in temporal trends.
Inequalities are avoidable differences and usually linked to
unequal opportunities of access to prevention or treatment.29
For the oldest women (≥80 years of age) the SES inequalities
in the trends seem to vanish, and this might be because social
inequalities can diminish with age.30 The most disadvantaged
survivors are in general very healthy since the less healthy will
have less probability of reaching older age.30 Only women aged
65–79 years in the afﬂuent regions, have a continuously decreas-
ing trend during all the study period. The strongest inequalities
were observed in women between 65 and 79 years of age and
increased during the BJD: while HF incidence persistently
decreases in the afﬂuent regions, the decrease in the medium
regions was only for a short period of 3 years and, in the
deprived regions, there was no decreasing period; besides, there
are increasing trends starting ﬁrst in 2006 in the deprived
regions and later, in 2007, in the medium regions. Our results
seem to show that HF reduction from 2000 to 2010 have
mainly reached a restricted group: women aged 65–79 years in
the afﬂuent regions, the preferential target population for medi-
cation and treatment against osteoporosis and HF,31 32 while
sustainable reduction seems to have failed for all the other men
and women. All stable or increasing trends in 2000 (for all age
groups and regional SES among women) turned to accentuate
decreasing trends around 2002/2003, although such turning
points were rarely observed for men. Abrupt changes in epi-
demiological trends are usually compatible with interventions,
or other events affecting population health, rather than with the
natural development of a disease. Apparently, in the beginning
of BJD, there were positive efforts to reduce HF. A National
Program Against Rheumatic Disease (NPARD) was implemented
by the Ministry of Health as a contribution to the BJD initiative.
The programme put these diseases in the national political
agenda, by pooling efforts of services and levels of healthcare
provision, and investment on primary, secondary and tertiary
prevention. The NPARD had the ﬁnal goal of inverting the
increasing trend of the problem.33 Also, a previous study identi-
ﬁed a sales increase, around 2003, of ﬁrst-line medication
against osteoporosis, mainly bisphosphonates, coincident with
decreasing trends of HF incidence among women in the 65–
79-year age group.34 However, our results show that in most of
the analysed groups the decreasing trends last for short periods
and new turning points with increasing trends started in 2006/
2007, continuing until 2010 and nullifying the positive effect of
the decreasing periods—at the end of the BJD, the age-speciﬁc
incidence rates in women (except those from afﬂuent regions,
with ages 65–79 years) are in the same magnitude, or even
higher, than in the beginning of the BJD and the SES inequal-
ities deepened. Some reasons might explain the abrupt turning
points to increasing trends after 2006/2007. The well-being of
the population worsened, especially among the elderly
(≥65 years of age) due to a revision (lowering) of the pensions
in 2007.35 Since 2007, the economic scenario has worsened as
Portugal faced severe consequences of the global economic/
ﬁnancial crisis.36 Experience and evidence from past recessions
show a negative impact of austerity policies on heath inequal-
ity.37 Recession periods can impact people’s lifestyles in several
ways, which in turn might affect long-term HF rates, although
we would expect that such an impact would reﬂect smooth
changes in the trends of HF. Abrupt changes, such as what we
observed, are more likely to be due to abrupt changes in society
with impacts on the population. The abrupt turn from
decreased to increased HF rates could be due to changes in the
guidelines for prescriptions of antiosteoporosis medication, for
instance. An analysis of medical prescriptions in the study
period could have been elucidative. Unfortunately, such data
were not available. However, there is no reason to believe that
during the study period physicians reduced the prescriptions,
since there was neither public disinvestment in health36 nor
changes in the Portuguese guidelines for osteoporotic treatment.
Reduction in antiosteoporosis medication prescriptions could
also be due to new evidence about the adverse effects of long-
term use of bisphosphonates.38 39 Nevertheless, this hypothesis
does not seem to be a reasonable explanation for the observed
differences in trends of HF because a reduction in prescriptions,
whatever the reason, would affect all the SES-age-sex groups
equally. Loss of adherence to antiosteoporosis treatment could
explain the increasing trends after 2006/2007. In the USA,
studies evaluating the adherence to osteoporosis medications
pointed out the main reasons for abandonment: drug-related
side effects, having multiple comorbid conditions and higher
cost.40 41 In Portugal, some patients reported difﬁculties in
accessing medicaments due to economic constraints, drugs for
chronic conditions being among those that patients most often
failed to acquire.36 The percentage of government participation
in the costs of medications in Portugal varies according to the
disease to be treated/controlled. Antiosteoporotic medicaments
(including generic) are only partially supported by the govern-
ment; therefore, all patients need to contribute a certain per-
centage (which varies according to the medication). For older
patients (who tend to be polymedicated) and for the most
deprived patients, any cost, however small, might be a heavy
burden in their budget. The more vulnerable segment of the
Figure 1 Estimated temporal trends (2000–2010) of age-speciﬁc incidence rates of hip fracture, per 100 000 persons-year (95% CI) by
socioeconomic status regions and age groups in women.
Table 1 Estimated absolute and relative changes in temporal trends (2000–2010) of age-specific incidence rates of hip fracture, per 100 000 persons-year, (95% CI) by SES regions and age groups
in women
AgGr SES Period AIR AAC PAC ARC PRC
AgGr50–64 Affluent 2000–2007* 33.2 (29.5 to 36.9) −0.6 (−1.2 to −0.1) −5.1 (−9.2 to −0.9) −1.9 (−3.2 to −0.4) −15.3 (−25.6 to −3.2)
2007–2010 28.2 (26.2 to 30.2) 0.9 (0.0 to 1.8) 3.7 (−0.1 to 7.4) 3.2 (−0.1 to 7.0) 12.8 (−0.2 to 28)
Medium 2000–2003 30.1 (24.4 to 35.7) 1.2 (−0.7 to 2.8) 4.8 (−2.9 to 11.1) 4 (−2.1 to 11.1) 15.9 (−8.4 to 44.5)
2003–2010 34.5 (30.6 to 38.5) −0.8 (−1.6 to 0.0) −6.4 (−13.1 to 0.1) −2.3 (−4.6 to 0) −18.5 (−36.4 to 0.2)
Deprived 2000–2007 42.6 (32.1 to 53.0) −0.9 (−2.6 to 0.8) −6.6 (−18 to 5.5) −2.2 (−5.1 to 2.5) −15.5 (−35.8 to 17.3)
2007–2010 36.1 (30.3 to 42.0) 1.1 (−1.4 to 3.6) 5.7 (−6.8 to 18.1) 3.2 (−3.5 to 10.9) 15.8 (−17.4 to 54.6)
AgGr65–79 Affluent 2000–2010* 342.6 (331.5 to 353.7) −5.8 (−7.1 to −4.5) −63.3 (−78 to −49.3) −1.7 (−2.0 to −1.3) −18.5 (−22.2 to −14.8)
Medium 2000–2001 289.0 (266.2 to 311.8) 13.4 (−1.2 to 28.2) 26.7 (−2.5 to 56.5) 4.6 (−0.4 to 10.6) 9.2 (−0.8 to 21.1)
2001–2004 315.3 (295.1 to 335.5) −1.1 (−7.8 to 5.9) −4.5 (−31.1 to 23.7) −0.4 (−2.4 to 2.0) −1.4 (−9.4 to 7.8)
2004–2007* 310.8 (292.1 to 329.5) −14.7 (−21.1 to −8.6) −58.8 (−84.2 to −34.5) −4.7 (−6.5 to −2.9) −18.9 (−26.1 to −11.7)
2007–2010* 251.7 (235.2 to 268.1) 8.5 (2.2 to 15.2) 34.1 (8.9 to 61) 3.4 (0.9 to 6.3) 13.5 (3.5 to 25.2)
Deprived 2000–2001 323.3 (293.1 to 353.6) 0.5 (−17.3 to 19.4) 0.9 (−34.5 to 38.8) 0.1 (−4.9 to 6.5) 0.3 (−9.8 to 13)
2001–2006 324.4 (303.2 to 345.6) −3.4 (−7.9 to 0.7) −20.6 (−47.5 to 4.1) −1.1 (−2.4 to 0.2) −6.3 (−14.1 to 1.3)
2006–2010* 303.8 (284.7 to 322.9) 10.0 (2.3 to 17.3) 49.8 (11.4 to 86.4) 3.3 (0.7 to 6.0) 16.4 (3.6 to 29.9)
AgGr80mais Affluent 2000–2004 1663.2 (1599.7 to 1726.8) 14.5 (−0.6 to 29.9) 72.5 (−3.1 to 149.5) 0.9 (0.0 to 1.8) 4.4 (−0.2 to 9.2)
2004–2007* 1737.0 (1693.1 to 1780.9) −31.5 (−45.9 to −16.5) −126 (−183.5 to −66.1) −1.8 (−2.6 to −1.0) −7.2 (−10.4 to −3.8)
2007–2010* 1611.4 (1571.3 to 1651.6) 43.1 (26.2 to 59.7) 172.2 (104.8 to 238.7) 2.7 (1.6 to 3.8) 10.7 (6.4 to 15.1)
Medium 2001–2002 1514.8 (1385.9 to 1643.8) 34.4 (−10.7 to 76.9) 120.6 (−37.4 to 269.2) 2.3 (−0.7 to 5.4) 7.9 (−2.3 to 18.9)
2002–2006* 1634.6 (1539.9 to 1729.3) −46.7 (−70.4 to −20.9) −233.6 (−352.2 to −104.7) −2.9 (−4.2 to −1.3) −14.3 (−20.9 to −6.7)
2006–2010* 1403.8 (1324.1 to 1483.4) 45.1 (13.1 to 81.8) 203.2 (58.8 to 368.2) 3.2 (0.9 to 6.1) 14.5 (4 to 27.2)
Deprived 2000–2003* 1486.2 (1337.4 to 1635.0) 68.9 (22.2 to 115) 275.8 (88.9 to 460.0) 4.7 (1.4 to 8.5) 18.6 (5.6 to 33.8)
2003–2007* 1759.8 (1646.0 to 1873.7) −34.1 (−62.0 to −3.6) −170.6 (−309.9 to −18.0) −1.9 (−3.4 to −0.2) −9.7 (−16.8 to −1.1)
2007–2010* 1591.8 (1490.0 to 1693.7) 52.1 (9.1 to 98.6) 208.4 (36.6 to 394.4) 3.3 (0.6 to 6.4) 13.1 (2.2 to 25.4)
AAC, annual absolute change, per 100 000 persons-year; AgGr, age group; AIR, age-specific incidence rates, per 100 000 persons-year, in the beginning of the period; ARC, annual relative change (%); PAC, period absolute change, per 100 000
persons-year; PRC, period relative change (%); SES, regional socioeconomic status.
*p<0.05 for temporal trend (significant change).
population is usually more adversely affected by poverty, job
insecurity, unemployment, and privatisation of goods and ser-
vices. Vulnerability results from an interaction between develop-
mental problems, personal incapacities, disadvantaged social
status, the inadequacy of interpersonal networks and support,
degraded neighbourhoods and environments.42 In times of
crisis, there is expected to be a deterioration of healthcare
seeking, various effects on providers, and a disease burden that
will especially affect the most deprived and the elderly popula-
tion.36 The loss of adherence due to economic constraints is a
plausible explanation for the trend patterns observed, since the
elderly and the more deprived population were the most
affected by the economic crisis and it is in these groups that
increasing trends were observed after 2007. Moreover, the
absence of a lag time between economic crisis and the increasing
turning points corroborates the hypothesis of loss of adherence
of antiosteoporotic medication.34 Most of the studies on the
health effects of the economic crisis have analysed aggregate
data focusing on population averages, and may have hidden the
existent inequalities between SES. Our online supplementary
material is an example of this; we present the results of an ana-
lysis for the whole period in each age and sex group, but
without SES stratiﬁcation, and we lose the capacity to identify
differences among groups. We observed roughly the same
pattern in all sex and age groups (two turning points), except
for men aged 50–64 years, and at different scales (see online
supplementary methods 2, ﬁgures S1, S2, tables S3 and S4). It
seems that analysing aggregated data (as most of the published
studies do) may hide SES inequalities. For example, in our
study, when we analysed HF without stratifying by SES groups,
we did not identify the decreased trend of HF in women aged
65–79 years in afﬂuent areas. In addition, inequalities tend to
rise during recessions since those of afﬂuent SES are better at
adapting to new and changing economic circumstances than
Figure 2 Estimated temporal trends (2000–2010) of age-speciﬁc incidence rates of hip fracture, per 100 000 persons-year (95% CI) by
socioeconomic status regions and age groups in men.
those of deprived SES. Among men there are also SES inequal-
ities in the trends, although not so evident as among women.43
We found age inequalities in the temporal trends of HF inci-
dence, with the oldest women in a disadvantageous position.
Only women over 80 years of age show increasing trends in all
the SES regions after 2006/2007, reinforcing our hypothesis
that the economic crisis in Portugal, which had a high impact
on the elderly regardless of their SES, may have contributed to
the observed trends. The elderly are usually polymedicated due
to several comorbidities and the antiosteoporosis medication is
among the ﬁrst abandoned medications40 44 in the face of eco-
nomic constraints. Furthermore, only for women aged
≥80 years from deprived regions was there an increasing trend
in the beginning of the BJD, and the later observed decreasing
periods were shorter in this age group. This might reﬂect age
inequalities in the priorities of intervention actions, targeting
younger women while the oldest are neglected.42 In general,
temporal trends are more stable in the youngest group of those
aged 50–64 years. Statistically, there is only one signiﬁcant
reduction period among women aged 50–64 years (0.6 HF per
100 000 per person-year in afﬂuent SES). However, the magni-
tude of this reduction is too small and might arguably be clinic-
ally irrelevant.
There are sex inequalities evident in the trends: during the
study period women in all age groups and SES regions (except
those aged <80 years in deprived regions) presented periods of
signiﬁcant decreasing trends in the age-speciﬁc incidence rates.
Among men, a reduction was observed only in two groups: ages
65–79 years in afﬂuent regions, and ages ≥80 years in the
medium regions. In general, trends among men are stable and
this might be a consequence of the lack of attention to men’s
bone health. Frequently, osteoporosis and HF are seen as a
woman’s problem and less attention is given to men in both—
prevention programmes and drug therapy. In men, drug therapy
has never reached the level that it has in women;45 although,
with their increasing longevity, more men will be at risk for
osteoporosis and HF,43 and interventions must be more inclu-
sive of men.
A limitation of our study is the non-existence of individual
data for the patients’ SES characterisation because the indivi-
dual’s socioeconomic data is not routinely collected. Therefore,
any conclusions need to be treated with caution, even though
the SES of the place of residence is frequently and adequately
used as a proxy of individual SES.10 46 Furthermore, the mea-
sures of municipality SES are helpful to recognise geographical
areas at high-risk of HF in order to better direct public health
intervention programmes. Recurrent fractures could not be iden-
tiﬁed because of conﬁdentiality issues (the patient unique identi-
ﬁer was not available), and this could be seen as a limitation
since the risk of a new fragility fracture increases after the
primary HF. However, our study focused on incidence rates of
HF (number of HF in a population at risk) rather than cumula-
tive incidence (number of persons with an HF in a population
at risk) and, therefore, such a limitation does not bias our
results.
Our study has the advantage of using population based on
repeated cross-sectional data from a nationwide register and
stratiﬁes the HF incidence per SES regions, sex and age groups,
allowing the identiﬁcation of different effects on trends and
clarifying hidden inequalities in the trends. The use of a multidi-
mensional SES that encapsulates a variety of domains, related to
building, households, families and individual characteristics, and
determined by an approach that allows reduction of the covari-
ates to a set of uncorrelated variables that explain much of the
original data, can be seen as an advantage. Despite the focus
that the BJD brought to studies on HF, little attention has been
given to the inequalities associated with this disorder and, to
our knowledge, this is the ﬁrst study analysing the temporal
trends of HF incidence by sex and age group for different SES
regions.
Our results can give insights on the real burden of HF and
help with better planning of health policies. Understanding posi-
tive and negative aspects of the initiatives triggered by BJD may
help to potentiate better results in the ongoing global alliance
for musculoskeletal health. In general, the abrupt decreasing
turning points found in our study seem to be plausibly
Table 2 Estimated absolute and relative changes in temporal trends (2000–2010) of age-specific incidence rates of hip fracture, per 100 000
persons-year, (95% CI) by SES regions and age groups in men
AgGr SES Period AIR AAC PAC ARC PRC
AgGr50–64 Affluent 2000–2010 24.4 (21.9 to 26.9) 0.0 (−0.3 to 0.3) 0.5 (−3.3 to 3.8) 0.2 (−1.1 to 1.5) 2.2 (−12.5 to 16.4)
Medium 2000–2010 26.0 (22.1 to 30.0) 0.0 (−0.5 to 0.5) −0.1 (−5.2 to 5.1) 0.0 (−1.7 to 2) −0.5 (−18.8 to 21.5)
Deprived 2000–2010 30.3 (23.0 to 37.5) 0.6 (−0.3 to 1.6) 6.6 (−3.7 to 18.1) 2.0 (−1 to 6.4) 21.6 (−10.7 to 70.1)
AgGr65–79 Affluent 2000–2001 137.6 (127.3 to 147.8) 0.0 (−6.1 to 6.5) 0.0 (−12.2 to 13) 0.0 (−4.0 to 5.1) 0.0 (−8.1 to 10.2)
2001–2007* 137.9 (130.8 to 145.1) −2.5 (−3.8 to −1.1) −17.3 (−26.3 to −7.4) −1.8 (−2.6 to −0.8) −12.6 (−18.3 to −5.6)
2007–2010 120.5 (114.6 to 126.4) 0.6 (−2.0 to 3.3) 2.4 (−8.1 to 13.2) 0.5 (−1.6 to 2.8) 2.0 (−6.5 to 11.3)
Medium 2000–2010 136.4 (125.9 to 146.8) −1.1 (−2.4 to 0.2) −11.8 (−26.3 to 2.3) −0.8 (−1.7 to 0.2) −8.6 (−18.2 to 1.8)
Deprived 2000–2004 139.8 (119.8 to 159.8) −1.5 (−6.2 to 3.2) −7.4 (−31.1 to 16.2) −1.1 (−4 to 2.5) −5.3 (−19.9 to 12.7)
2004–2010* 132.8 (120.8 to 144.9) 5.9 (1.9 to 10.2) 41.6 (13.2 to 71.4) 4.4 (1.4 to 7.9) 31.1 (9.9 to 55.5)
AgGr80mais Affluent 2000–2006 719.7 (670.8 to 768.5) −0.8 (−9.1 to 7.6) −5.6 (−63.6 to 53.2) −0.1 (−1.2 to 1.1) −0.8 (−8.3 to 7.9)
2006–2010* 713.1 (685.4 to 740.8) 11.1 (0.5 to 20.8) 55.3 (2.7 to 103.9) 1.6 (0.1 to 3.0) 7.8 (0.4 to 14.9)
Medium 2000–2003 660.3 (592.3 to 728.4) 11.5 (−8.8 to 31.4) 45.8 (−35.0 to 125.6) 1.7 (−1.3 to 5.2) 7.0 (−5.1 to 20.7)
2003–2007* 706.0 (661.0 to 751.0) −16.2 (−28.3 to −4.6) −81.0 (−141.4 to −22.8) −2.3 (−3.8 to −0.7) −11.5 (−19.1 to −3.4)
2007–2010 625.1 (586.0 to 664.2) 3.5 (−13.0 to 20.0) 13.8 (−52.0 to 80.2) 0.5 (−2.0 to 3.3) 2.2 (−8.0 to 13.3)
Deprived 2000–2006 726.5 (638.8 to 814.1) −4.8 (−19.1 to 9.9) −33.3 (−133.7 to 69.1) −0.7 (−2.4 to 1.6) −4.6 (−16.5 to 10.9)
2006–2010 694.3 (644.9 to 743.6) 12.2 (−6.0 to 31.0) 60.8 (−29.8 to 154.9) 1.7 (−0.8 to 4.6) 8.7 (−4.2 to 23.1)
AAC, annual absolute change, per 100 000 persons-year; AgGr, age group; AIR, age-specific incidence rates, per 100 000 persons-year, in the beginning of the period; ARC, annual
relative change (%); PAC, period absolute change, per 100 000 persons-year; PRC, period relative change (%); SES, regional socioeconomic status.
*p<0.05 for temporal trend (significant change).
explained by an intervention, likely based on increased treat-
ment (eg, antiosteoporosis medication) and prevention pro-
grammes observed since the beginning of the BJD, with an
impact on the incidence rates in all ages and SES groups among
women. Coincident with the beginning of the economic crisis in
Portugal, the most deprived and oldest groups returned to
increased trends, reaching similar or even higher rates in 2010
than those observed in 2000.
CONCLUSIONS
There are socioeconomic, age and sex inequalities in temporal
trends of age-speciﬁc incidence rates in Portugal during the
BJD. The inequalities in trends are especially marked in women
between 65 and 79 years of age: only those living in afﬂuent
areas have a continuously decreasing trend while the medium
and deprived regions have increasing trends after 2007. The
SES inequalities observed in women aged <80 years disappear
in the oldest age group (≥80 years). It seems that HF prevention
during the BJD in Portugal has reached mainly women (65–
79 years of age) in the afﬂuent areas while it has failed for all
the other age groups. Clear sex inequalities were observed: only
two groups of SES/age in men presented a decreasing period, as
opposed to the majority of SES/age groups in women. Overall,
the trends among men are stable, which could reﬂect the lack of
attention given to bone health among men.
Despite some successful periods of decreasing trends, at the
end of the BJD, the incidence rates returned to the values of
2000, or were even higher, in almost all age groups, in men and
women.
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